TICE BCG 50 mg Powder for Intravesical Suspension, Single-Dose Vial

Tice Bcg — 50MG, Powder for suspension, carton of 1 × 50 mL vial

Tice Bcg (BACILLUS CALMETTE-GUERIN) is a powder for suspension for intravesical use. TICE ® BCG is indicated for: the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR) Limitations of Use: TICE BCG is not recommended for stage TaG1 papillary tumors, unless they are judged to be at high risk of tumor recurrence. TICE BCG is not indicated for papillary tumors of stages higher than T1.

• Active ingredient or product type: BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
• Strength/concentration: 50MG
• Dosage form and route: Powder for suspension, Intravesical
• Exact package presentation: carton of 1 × 50 mL vial
• NDC/item number: 0052-0602-02
• Manufacturer: MERCK & CO / USHH PDP
• Storage/handling: Store refrigerated according to the current product labeling.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.